共 9 条
[1]
[2]
Advances in the management of acute liver failure[J] Da-Wei Wang;Yi-Mei Yin;Yong-Ming Yao; World Journal of Gastroenterology 2013,
[3]
Effect evaluation of interleukin-1 receptor antagonist nanoparticles for mesenchymal stem cell transplantation[J] Xiao-Lei Shi;Wei Zhu;Jia-Jun Tan;Jiang-Qiang Xiao;Lin Zhang;Qian Xu;Zheng-Liang Ma;Yi-Tao Ding; World Journal of Gastroenterology 2013,
[4]
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J] Shiv Kumar Sarin;Chandan Kumar Kedarisetty;Zaigham Abbas;Deepak Amarapurkar;Chhagan Bihari;Albert C. Chan;Yogesh Kumar Chawla;A. Kadir Dokmeci;Hitendra Garg;Hasmik Ghazinyan;Saeed Hamid;Dong Joon Kim;Piyawat Komolmit;Suman Lata;Guan Huei Lee;Laurentius A. Lesmana;Mamun Mahtab;Rakhi Maiwall;Richard Moreau;Qin Ning;Viniyendra Pamecha;Diana Alcantara Payawal;Archana
[5]
Toward an Improved Definition of Acute-on-Chronic Liver Failure[J] Rajiv Jalan Gastroenterology 2014,
[6]
Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder[J] Sigrun Hope;Thor Ueland;Nils Eiel Steen;Ingrid Dieset;Steinar Lorentzen;Akiah O. Berg;Ingrid Agartz;Pål Aukrust;Ole A. Andreassen Schizophrenia Research 2013,
[7]
Inflammasome and cytokine blocking strategies in autoinflammatory disorders[J] Monika Moll;Jasmin B. Kuemmerle-Deschner Clinical Immunology 2013,
[8]
Hepatic acute phase proteins – Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling[J] European Journal of Cell Biology 2011,
[9]
Immunological and Inflammatory Functions of the Interleukin-1 Family[J] Charles A. Dinarello Annual Review of Immunology 2009,

